Quantitative Systems Pharmacology Modeling of Loncastuximab Tesirine Combined With Mosunetuzumab and Glofitamab Helps Guide Dosing for Patients With DLBCL

Autor: Li, Yuezhe, Katharina Wilkins, A., Knab, Timothy, Keir, Chris, Boni, Joseph P.
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia September 2024 24 Supplement 1:S216-S216
Databáze: ScienceDirect